Repression of α-synuclein expression and toxicity by microRNA-7
Top Cited Papers
- 4 August 2009
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (31) , 13052-13057
- https://doi.org/10.1073/pnas.0906277106
Abstract
Alpha-Synuclein is a key protein in Parkinson's disease (PD) because it accumulates as fibrillar aggregates in pathologic hallmark features in affected brain regions, most notably in nigral dopaminergic neurons. Intraneuronal levels of this protein appear critical in mediating its toxicity, because multiplication of its gene locus leads to autosomal dominant PD, and transgenic animal models overexpressing human alpha-synuclein manifest impaired function or decreased survival of dopaminergic neurons. Here, we show that microRNA-7 (miR-7), which is expressed mainly in neurons, represses alpha-synuclein protein levels through the 3'-untranslated region (UTR) of alpha-synuclein mRNA. Importantly, miR-7-induced down-regulation of alpha-synuclein protects cells against oxidative stress. Further, in the MPTP-induced neurotoxin model of PD in cultured cells and in mice, miR-7 expression decreases, possibly contributing to increased alpha-synuclein expression. These findings provide a mechanism by which alpha-synuclein levels are regulated in neurons, have implications for the pathogenesis of PD, and suggest miR-7 as a therapeutic target for PD and other alpha-synucleinopathies.Keywords
This publication has 48 references indexed in Scilit:
- miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesisNature Neuroscience, 2008
- Mitochondrial localization of DJ‐1 leads to enhanced neuroprotectionJournal of Neuroscience Research, 2008
- The impact of microRNAs on protein outputNature, 2008
- Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expressionProceedings of the National Academy of Sciences, 2008
- Variation in the miRNA-433 Binding Site of FGF20 Confers Risk for Parkinson Disease by Overexpression of α-SynucleinPublished by Elsevier ,2008
- Cerebellar neurodegeneration in the absence of microRNAsThe Journal of Experimental Medicine, 2007
- The neuronal microRNA systemNature Reviews Neuroscience, 2006
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998